Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B

来源 :世界胃肠病学杂志:英文版(电子版) | 被引量 : 0次 | 上传用户:ankailvyou
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
AIM:To compare the efficacy and safety of tenofovir disoproxil fumarate(TDF)in Asian and non-Asian chronic hepatitis B(CHB)patients.METHODS:The efficacy and safety of the initial 48wk of treatment with TDF was compared in a posthoc analysis of combined da
其他文献
AIM To evaluate whether an endoscopy positiondetecting unit (UPD-3) can improve cecal intubationrates, cecal intubation times and visual analog scale(VAS) pain scor
AIM To create a new rat model for drug administration,cell transplantation, and endoscopic examination for thetreatment of intestinal diseases.METHODS: F344/NJc
Severe complications of liver cirrhosis are mostlyrelated to portal hypertension. At the base of thepathogenesis of portal hypertension is the increase inhepati
AIM To investigate the outcome of palliative chemotherapyin old patients with gastroesophageal cancer atthe National Center for Tumor Diseases, Heidelberg.METHO
AIM: To identify the factors that differentiate acute hepatitis B(AHB) from chronic hepatitis B with acute exacerbation(CHB-AE).METHODS: From 2004 to 2013, a to
AIM To investigate the change in intestinal dendriticcell (DC) number in fulminant hepatic failure (FHF).METHODS: An animal model of FHF was created.Intestinal CD11b
Strongyloides stercoralis,a soil transmitted helminth infection,affects millions with varying prevalence worldwide.A large number of affected hosts are asymptom
Celiac disease (CD) is an intestinal inflammatory diseasethat manifests in genetically susceptible individualswhen exposed to dietary gluten. It is a common chron
AIM: To investigate the performance of GadofluorineP-enhanced magnetic resonance imaging (MRI) onthe diagnosis of diabetes in a streptozotocin (STZ)-induced diabetic
Patients with pancreatic cancer have a poor prognosiswith a median survival of 4-6 mo and a 5-year survivalof less than 5%. Despite therapy with gemcitabine,pat